The Prevalence of Cigarette Smoking, Alcohol Consumption, Psychostimulant and Cannabinoid Drugs Abuse among 15 to 35 Years Old Tehranis

authors:

avatar Mustafa Hamdieh 1 , * , avatar Ashraf Borujerdi 2 , avatar Nabi Motalebi 3 , avatar Maryam Abbasinejad 2 , avatar Hossein Asheri 2 , avatar Amir Motamedi 3

Associate Professor of Psychiatry, Taleghani Hospital, Tehran, Iran
Tehran University of Medical Sciences, Tehran, Iran
Iranian Academic Center for Education, Culture, and Research, Tehran University of Medical Sciences, Tehran, Iran

How To Cite Hamdieh M, Borujerdi A, Motalebi N, Abbasinejad M, Asheri H, et al. The Prevalence of Cigarette Smoking, Alcohol Consumption, Psychostimulant and Cannabinoid Drugs Abuse among 15 to 35 Years Old Tehranis. Iran J Psychiatry Behav Sci. 2010;4(2): 26-30. 

Abstract

Objective: This cross-sectional study was performed to give us a comprehensive view on the prevalence of cigarette smoking, alcohol consumption, psychostimulants, and cannabinoid drug abuse among teenagers and adults ranging 15 to 35 years old residing in Tehran during the first 6 months of the year 2005.
Methods: Eight thousand one hundred and seventy five individuals from the 22 city councils participated in a survey from January to June 2005.
Results: In answer to the question about psychostimulant drug abuse, 89.5% answered "No", 7% answered "Yes" and 3.6% did not answer this question. The prevalence of cannabinoid drug abuse was 3.8%, psychostimulant drug abuse 7.2%, and alcohol consumption 25.7%. Mean age in each group of substance abusers was similar to that of the whole sample and significantly higher in males. Marriage was a variable which had a significant correlation with low prevalence of drug abuse and alcohol consumption.
Conclusion:The frequency of alcohol consumption is high in our sample (25.7%) proceeded by psychostimulant (7.2%) and cannabinoid drug abuse (3.8%).
Declaration of interest: None.

Fulltext

Full text is available in the PDF.

References

  • 1.

    References are available in the PDF.